LYTIR

Company · ELV

Elevance Health, Inc.

Nasdaq's symbol directory lists ELV on the New York Stock Exchange as “Elevance Health, Inc. Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($1.4M); insiders sold on 5 occasions ($6.1M); 3 planned-sale notices; 8 congressional trade disclosures; 4 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $1.4M in total; Insider sales: $6.1M in total.May: Insider sales $617KJun: Insider sales $209KJul: Insider purchases $1.4MOct: Insider sales $4.7MNov: Insider sales $572KDecJanFebMarAprMayJunJulAugSepOctNov$1.4M$4.7M
Insider purchases above the line: $1.4MInsider sales below: $6.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Kaye Mark, EVP & CFO sold on 1 day latest Oct 22, 2026 sold $4.7M
  2. BOUDREAUX GAIL, President and CEO bought on 1 day latest Jul 17, 2026 bought $1.0M
  3. Penczek Ronald W, CAO & Controller sold on 2 days latest Jun 12, 2026 sold $766K
  4. LAVU RATNAKAR, EVP & Chief Digital Info Ofr sold on 1 day latest Nov 5, 2026 sold $572K
  5. PERU RAMIRO G bought on 1 day latest Jul 17, 2026 bought $366K
  6. Dixon Robert L JR sold on 1 day latest Jun 11, 2026 sold $61K
Every trade (7)
  1. SELLLAVU RATNAKAR, EVP & Chief Digital Info Ofr sold Nov 5, 2026 1,300 shares filing $572K
  2. SELLKaye Mark, EVP & CFO sold Oct 22, 2026 10,584 shares 13 legs combined filing $4.7M
  3. BUYBOUDREAUX GAIL, President and CEO bought Jul 17, 2026 2,725 shares 2 legs combined filing $1.0M
  4. BUYPERU RAMIRO G bought Jul 17, 2026 1,000 shares filing $366K
  5. SELLPenczek Ronald W, CAO & Controller sold Jun 12, 2026 369 shares filing $149K
  6. SELLDixon Robert L JR sold Jun 11, 2026 151 shares filing $61K
  7. SELLPenczek Ronald W, CAO & Controller sold May 19, 2026 1,531 shares filing $617K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. RATNAKAR LAVU filed Nov 5, 2026 Officer 1,300 shares planned sale date 11/05/2026 filing $572K
  2. MARK B KAYE filed Oct 22, 2026 Officer 10,584 shares planned sale date 10/22/2026 filing $4.7M
  3. CLARK R KERRY filed Jul 7, 2026 Director 1,500 shares planned sale date 07/07/2026 filing $630K

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Rohit Khanna (D-CA17): Sale Jul 20, 2026 reported Aug 7, 2026 one of 257 trades the member reported that day House owner: spouse $1,001 - $15,000
  2. Rohit Khanna (D-CA17): Purchase May 15, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: spouse $1,001 - $15,000
  3. Rohit Khanna (D-CA17): Purchase Apr 13, 2026 reported May 11, 2026 one of 348 trades the member reported that day House owner: spouse $1,001 - $15,000
  4. Alan Armstrong (R-OK): Purchase Mar 27, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000
  5. Rohit Khanna (D-CA17): Purchase Feb 17, 2026 reported Mar 9, 2026 one of 274 trades the member reported that day House owner: spouse $1,001 - $15,000
  6. Rohit Khanna (D-CA17): Sale Jan 29, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: spouse $1,001 - $15,000
  7. Rohit Khanna (D-CA17): Purchase Jan 23, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: dependent $1,001 - $15,000
  8. Markwayne Mullin (R-OK): Purchase Dec 29, 2025 reported Jan 16, 2026 one of 31 trades the member reported that day Senate Stock $15,001 - $50,000

Executive branch · OGE Form 278-T

Reported by the President

3 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports

  1. Purchase: ELEVANCE HEALTH INC Apr 27, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $1,001 – $15,000
  2. Purchase: ELEVANCE HEALTH INC Apr 27, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $15,001 – $50,000
  3. Purchase: ELEVANCE HEALTH INC Apr 10, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $50,001 – $100,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Nov 10, 2026
  2. Results of operations and financial condition filing Oct 21, 2026
  3. Regulation FD disclosure filing Sep 10, 2026
  4. Results of operations and financial condition filing Jul 15, 2026

Lobbying · Senate LDA reports

Lobbying filed

13 quarterly lobbying reports for 2026 naming Elevance Health, Inc. as the client: 3 filed by the company itself, 10 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.

  1. The company itself Q2 2026 filing $2.3M
  2. TIBER CREEK GROUP Q2 2026 filing $90K
  3. MEHLMAN CONSULTING, INC. Q2 2026 filing $90K
  4. TARPLIN, DOWNS & YOUNG, LLC Q2 2026 filing $80K
  5. CAPITOL HILL CONSULTING GROUP Q2 2026 filing $60K
  6. ALB SOLUTIONS Q2 2026 filing $60K
  7. The company itself Q1 2026 filing $2.1M
  8. The company itself Q1 2026 filing $1.7M
  9. MEHLMAN CONSULTING, INC. Q1 2026 filing $90K
  10. TIBER CREEK GROUP Q1 2026 filing $90K
  11. TARPLIN, DOWNS & YOUNG, LLC Q1 2026 filing $80K
  12. ALB SOLUTIONS Q1 2026 filing $60K
  13. CAPITOL HILL CONSULTING GROUP Q1 2026 filing $60K

Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.